Health-related quality of life (e.g., physical and mental health) 2. Functional status (e.g., ability to perform normal daily activities to meet basic needs, fulfill usual roles, and maintain health and well-being) 3. Symptom reduction (e.g., how patients can have fewer symptoms) 4. Adherence (e.g., having closer agreement between what the patient wants to do for self-care and what they have been advised to do such as taking medicines, quitting smoking) 5. Quitting smoking and staying quit 6. Risk reduction (e.g., identify what things will help decrease risk for a complication, a disease or other unwanted outcomes) 7. Patient education focused on risk reduction (e.g., teaching patients and families how to decrease risk for a complication, a disease or other unwanted outcomes) 8. Ways to motivate health promotion/health-seeking behaviors (e.g., enabling people to increase control over, and to improve, their health) 9. Symptom overlap -better management strategies for symptoms that have multiple underlying causes (COPD and CHF exacerbation) 10. Technology to support self-care (e.g., telehealth, home spirometry) 11. Effective communication by the health care team (e.g., using plain language to explain diseases, medical tests and treatments) 12. Effective communication between patients and families and the health care team 13. Personalized care (e.g., care that is tailored to help patients and families better understand the direction or course of their particular lung disease) 14. Personalized care (understanding which models of care are appropriate and which treatments are effective at different time points across the trajectory of illness) 15. Advance care planning. This is a negotiated plan that tells the health care team what patients want for care if they are unable to speak for themselves. It is based on their own values, preferences, and discussions with their loved ones. 16. Anticipatory grief. This means learning how best to give patients and families bad news early and how best to respond to patient/family grief (e.g., refer to support groups or mental health specialists in end of life care). 17. Pre-symptom management. This is the effectiveness of services aimed at preventing or slowing the development of lung disease or its symptoms (e.g., pulmonary rehab in early stage COPD). 18. Low-cost simple treatments in places where resources are limited or unavailable (e.g., community walking programs instead of pulmonary rehab) 19. Culturally-competent tailored care (e.g., delivering care based on sex, age, culture, etc.) 20. Social support (e.g., helping friends/family to maximize quality outcomes in their loved ones) E6 21. Non-pharmacologic interventions. These are ways to help patients with lung disease besides using medicines (e.g., pulmonary rehabilitation, psychological support, handheld fans)* 22. Effectiveness of support groups early in progression (long term impact on cost; online vs Face To Face) Patient-reported experiences 1. Quitting smoking and staying quit 2. Patients feelings of stigma, shame, or guilt* 3. The impact of interventions that promote health 4. How patients and families make decisions about health 5. The burden of having more than one illness 6. Patients' and families' health beliefs 7. How patients and families think, understand, learn, and remember. 8. How patients and families get, process, and understand basic health information and services to arrive at a health decision. 9. What families understand about what patients need in order to take care of their disease or symptoms 10. What patients and families understand about the progression or prognosis of lung disease (e.g., will the symptoms get worse or will the disease never be cured?) 11. What it is like for patients and families to live with the uncertainty of what the future holds because of a lung disease diagnosis 12. What it is like for patients and families to create an advanced care plan. This is a negotiated plan to tell the health care team what care they want if they are unable to speak. It is based on their values, preferences and discussions with loved one 13. What it is like for patients and families to disagree with all, or some, of the advice the health care team has made regarding treating a lung disease or symptom* 14. What patients and families have found to be helpful in motivating them to care for their disease or symptoms 15. What it has been like for patients and families to prepare for loss. This means responding to bad news (e.g., a disease cannot be cured or that symptoms will get worse) 16 . How families can be helped to better understand what patients are experiencing 17. What it is like for patients and families to be diagnosed with a lung disease and to accept the diagnosis 18. How much social support patients and families have, or do not have, and how that impacts health. 19. Lung disease in the context of the conditions in which patients were born, grew up, work, live, and age, and the wider set of forces and systems that shape the conditions of their daily life (e.g., education, income, racism, etc.)* 20. How patients and families manage or navigate complex health service processes (e.g., insurance, health systems, etc.)* 21. How scientific evidence, patients' and families' values, preferences and needs lead to certain health behaviors** 22. How patients and families experience good and poor communication with the health care team.
E7
To better understand the experiences of the patient/family, nurses should…. has advised them to do (e.g. taking medicines, quitting smoking) 5. How best to quit smoking and stay quit 6. Ways to decrease the risk of a complication, a disease or other unwanted outcome 7. Best ways to teach individuals with lung disease, or their families, about how they can decrease the risk for a complication, a disease or other unwanted outcomes 8. Best ways to help individuals increase control over, and improve, their health 9. Better ways to recognize and manage more than one symptom 10. Access to, and skills to support self-care using, technology (e.g., telehealth, home spirometry) 11. Effective communication by the health care team (e.g., using plain language to explain diseases, medical tests and treatments) 12. Best ways for patients and families to talk with the health care team 13. Care that is tailored to help patients and families better understand the direction or course of their particular lung disease 14. Which models of care are right for what people at what time in their illness 15. Advanced care planning. This is a 'play book' that tells the health care team what patients want for care if they are unable to speak for themselves. It is based on their own values, preferences, and discussions with their loved ones 16. Anticipatory grief. This means learning how best to give patients and families bad news and how best to respond to patient/family grief (e.g., refer to support groups or mental health specialists in end of life care) 17. The effectiveness of services aimed at preventing or slowing the development of lung disease or its symptoms (e.g., pulmonary rehab in early stage COPD). 18. Low-cost simple treatments in places where resources are limited or unavailable (e.g., community walking programs instead of pulmonary rehab) 19. Care tailored to patients and families based on their culture, sex, age, etc.) 20. Best ways friends/family can help patients 21. Ways to help patients with lung disease besides using medicines (e.g., pulmonary rehabilitation, psychological support)** 22. The effects of early referral to support groups (e.g., long term impact on cost; benefits of online vs. Face To Face meetings) Patient-Reported Experiences 1. Quitting smoking and staying quit E9 2. Feelings of stigma, shame, or guilt* 3. The impact of interventions that promote health 4. How patients and families make decisions about health 5. The burden of having more than one illness 6. Patients' and families' health beliefs** 7. How patients and families think, understand, learn, and remember. 8. How patients and families get, process, and understand basic health information and services to arrive at a health decision. 9. What families understand about what patients need in order to take care of their disease or symptoms 10. What patients and families understand about the progression or prognosis of lung disease (e.g., will the symptoms get worse or will the disease never be cured?) 11. What it is like for patients and families to live with the uncertainty of what the future holds because of a lung disease diagnosis 12. What it is like for patients and families to create an advanced care plan.This is a 'play book' that tells the health care team what care they want if they are unable to speak. It is based on their values, preferences, and discussions with loved ones 13. What it is like for patients and families to disagree with all, or some, of the advice the health care team has made regarding treating a lung disease or symptom* 14. What patients and families have found to be helpful in motivating patients to care for their disease or symptoms 15. What it has been like for patients and families to prepare for loss. This means responding to bad news (a disease cannot be cured or that symptoms will get worse). 16 . How families can be helped to better understand what patients are experiencing. 17. What it is like for patients and families to be diagnosed with a lung disease and to accept the diagnosis 18. How much social support patients and families have, or do not have, and how that impacts health. This is any kind of help from individuals who care about the patient or family. 19. Lung disease in the context of the conditions in which patients were born, grew up, work, live, and age, and the wider set of forces and systems that shape the conditions of their daily life (education, income, racism, etc.)* 20. How patients and families manage or navigate complex health service processes (e.g., insurance, health systems, etc.)* 21. How scientific evidence, patients' and families'/caregivers' values, preferences and needs lead to certain health behaviors 22 Table E7 . Adult Respiratory Health -Nurses Version Round 2 items -revised to specify "caregivers" Patient-Reported Outcomes
